Glow-in-the-Dark dye helps surgeons find colon cancer
NCT ID NCT07380867
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a dye mixture called Luminomark, which is injected into the colon wall near a tumor during a colonoscopy. The dye glows under a special camera during surgery, helping surgeons see exactly where to cut. The study involves 30 adults with early-stage colorectal cancer who need surgery. The goal is to see if this marking method improves surgical accuracy and reduces unnecessary tissue removal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Indocyanine Green (ICG) and Hyaluronic Acid mixture (Luminomark)
- What this could lead to
- If successful, this marking method could help surgeons locate colon tumors more accurately during surgery, reducing the need for extra tissue removal.
- What could go wrong
- This is a small, early-stage study with only 30 participants. The dye may not always be visible or could cause minor side effects like fever or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul St.Mary's hospital, the Catholic university of Korea
Seoul, Seoul, 06591, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?